[unable to retrieve full-text content]
- U.S. millions of doses behind COVID-19 vaccine targets CBC News: The National
- Moderna Stock Is More Than The Covid-19 Vaccine InvestorPlace
- Your Thursday Briefing The New York Times
- Coronavirus | Moderna COVID-19 vaccine shows 94.1% efficacy in trial: Study The Hindu
- View Full coverage on Google News
https://news.google.com/__i/rss/rd/articles/CBMiK2h0dHBzOi8vd3d3LnlvdXR1YmUuY29tL3dhdGNoP3Y9LUpCaDVjT1ZZaW_SAQA?oc=5
2021-01-02 03:32:32Z
52781280907724
Tidak ada komentar:
Posting Komentar